Literature DB >> 30943030

Review of Transient Receptor Potential Canonical (TRPC5) Channel Modulators and Diseases.

Swagat Sharma1, Corey R Hopkins1.   

Abstract

Transient receptor potential canonical (TRPC) channels are highly homologous, nonselective cation channels that form many homo- and heterotetrameric channels. These channels are highly abundant in the brain and kidney and have been implicated in numerous diseases, such as depression, addiction, and chronic kidney disease, among others. Historically, there have been very few selective modulators of the TRPC family in order to fully understand their role in disease despite their physiological significance. However, that has changed recently and there has been a significant increase in interest in this family of channels which has led to the emergence of selective tool compounds, and even preclinical drug candidates, over the past few years. This review will cover these new advancements in the discovery of TRPC modulators and the emergence of newly reported structural information which will undoubtedly lead to even greater advancements.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30943030     DOI: 10.1021/acs.jmedchem.8b01954

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  16 in total

1.  Synthesis of the quinazolinone derivatives using an acid-functionalized magnetic silica heterogeneous catalyst in terms of green chemistry.

Authors:  Saeid Ahmadizadeh Shendy; Mirzaagha Babazadeh; Gholam Hossein Shahverdizadeh; Rahim Hosseinzadeh-Khanmiri; Moosa Es'haghi
Journal:  Mol Divers       Date:  2020-02-20       Impact factor: 2.943

Review 2.  Charting a TRP to Novel Therapeutic Destinations for Kidney Diseases.

Authors:  Juan Lorenzo Pablo; Anna Greka
Journal:  Trends Pharmacol Sci       Date:  2019-11-05       Impact factor: 14.819

Review 3.  Beta-Cell Ion Channels and Their Role in Regulating Insulin Secretion.

Authors:  Benjamin Thompson; Leslie S Satin
Journal:  Compr Physiol       Date:  2021-10-12       Impact factor: 9.090

4.  Structural identification of riluzole-binding site on human TRPC5.

Authors:  Yaxiong Yang; Miao Wei; Lei Chen
Journal:  Cell Discov       Date:  2022-07-12       Impact factor: 38.079

5.  Novel Pyridazinones as TRPC5 Inhibitors for Treating Kidney Diseases.

Authors:  Ram W Sabnis
Journal:  ACS Med Chem Lett       Date:  2021-03-16       Impact factor: 4.345

6.  PIP2 regulation of TRPC5 channel activation and desensitization.

Authors:  Mehek Ningoo; Leigh D Plant; Anna Greka; Diomedes E Logothetis
Journal:  J Biol Chem       Date:  2021-04-29       Impact factor: 5.157

7.  Synthesis and Characterization of a Specific Iodine-125-Labeled TRPC5 Radioligand.

Authors:  Yanbo Yu; Qianwa Liang; Lixia Du; Hao Jiang; Jiwei Gu; Hongzhen Hu; Zhude Tu
Journal:  ChemMedChem       Date:  2020-09-02       Impact factor: 3.540

8.  Human TRPC5 structures reveal interaction of a xanthine-based TRPC1/4/5 inhibitor with a conserved lipid binding site.

Authors:  David J Wright; Katie J Simmons; Rachel M Johnson; David J Beech; Stephen P Muench; Robin S Bon
Journal:  Commun Biol       Date:  2020-11-23

Review 9.  Taste the Pain: The Role of TRP Channels in Pain and Taste Perception.

Authors:  Edwin N Aroke; Keesha L Powell-Roach; Rosario B Jaime-Lara; Markos Tesfaye; Abhrarup Roy; Pamela Jackson; Paule V Joseph
Journal:  Int J Mol Sci       Date:  2020-08-18       Impact factor: 5.923

10.  (-)-Englerin-A Has Analgesic and Anti-Inflammatory Effects Independent of TRPC4 and 5.

Authors:  João de Sousa Valente; Khadija M Alawi; Sabah Bharde; Ali A Zarban; Xenia Kodji; Dibesh Thapa; Fulye Argunhan; Brentton Barrett; Istvan Nagy; Susan D Brain
Journal:  Int J Mol Sci       Date:  2021-06-15       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.